GSK-205021

Study Sponsor: GSK

Study Title

A single-centre, randomized, double-blind (sponsor open), placebo-controlled study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of GSK2983559, in single (in both fed and fasted states) and repeat oral doses in healthy participants

Medicine or Vaccine (generic name)

GSK2983559

Sponsor Identification Number

205021

Trial Registry Identification Number(#'s)

NCT03358407 2017-002664-40

Medical Condition

Inflammatory Bowel Diseases

Phase

Phase 1

Link to study details on the GSK Clinical Study Register

https://www.gsk-studyregister.com/en/trial-details/?id=205021

Link to study details on ClinicalTrials.gov (if available)

http://clinicaltrials.gov/show/NCT03358407

Link to study details on EudraCT (if available)

https://www.clinicaltrialsregister.eu/ctr-search/search?query=/2017-002664-40

Datasets and Documents Available for this Study

Raw dataset	Annotated case report form	Dataset specifications	Protocol with any amendments
Analysis-ready dataset	Reporting and analysis plan	Clinical study report	Ready to Share

Additional information about the data and documents available for this study

An annotated case report form is not available for this study. A blank case report form will be provided.

Date Added to this Site

September 2020